Terms: = Prostate cancer AND ZNF198, Q9UBW7, SCLL, RAMP, MYM, FIM, 7750
12 results:
1. MR image quality in local staging of prostate cancer: Role of PI-QUAL in the detection of extraprostatic extension.
Ponsiglione A; Stanzione A; Califano G; De Giorgi M; Collà Ruvolo C; D'Iglio I; Morra S; Longo N; Imbriaco M; Cuocolo R
Eur J Radiol; 2023 Sep; 166():110973. PubMed ID: 37453275
[TBL] [Abstract] [Full Text] [Related]
2. Decision-making for intensive rehabilitation in patients with Trousseau syndrome: Insights from a case series.
Takeshima S; Kawate N
Medicine (Baltimore); 2023 Jun; 102(26):e34097. PubMed ID: 37390272
[TBL] [Abstract] [Full Text] [Related]
3. [The value of DISCO and MUSE-DWI combined with prostate specific antigen density in the diagnosis and risk stratification of prostate cancer].
Chen ZQ; Zhang D; Wang Z; Song N; Ma AL; Zhang SR; Cai L
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1461-1468. PubMed ID: 37198108
[No Abstract] [Full Text] [Related]
4. Testosterone replacement in prostate cancer survivors with testosterone deficiency: Study protocol of a randomized controlled trial.
Valderrábano RJ; Pencina K; Storer TW; Reid KF; Kibel AS; Burnett AL; Huang G; Dorff T; Privat F; Ghattas-Puylara C; Wilson L; Latham NK; Holmberg M; Bhasin S
Andrology; 2023 Jan; 11(1):93-102. PubMed ID: 36181480
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.
Zirimwabagabo JO; Jailani ABA; Avgoustou P; Tozer MJ; Gibson KR; Glossop PA; Mills JEJ; Porter RA; Blaney P; Wang N; Skerry TM; Richards GO; Harrity JPA
J Med Chem; 2021 Mar; 64(6):3299-3319. PubMed ID: 33666424
[TBL] [Abstract] [Full Text] [Related]
6. Role of receptor activity modifying protein 1 in function of the calcium sensing receptor in the human TT thyroid carcinoma cell line.
Desai AJ; Roberts DJ; Richards GO; Skerry TM
PLoS One; 2014; 9(1):e85237. PubMed ID: 24454825
[TBL] [Abstract] [Full Text] [Related]
7. Quantification of differences in the effective atomic numbers of healthy and cancerous tissues: a discussion in the context of diagnostics and dosimetry.
Taylor ML
Med Phys; 2012 Sep; 39(9):5437-45. PubMed ID: 22957611
[TBL] [Abstract] [Full Text] [Related]
8. The use of non-standard CT conversion ramps for Monte Carlo verification of 6 MV prostate IMRT plans.
Zarza-Moreno M; Cardoso I; Teixeira N; Jesus AP; Mora G
Phys Med; 2013 Jun; 29(4):357-67. PubMed ID: 22677401
[TBL] [Abstract] [Full Text] [Related]
9. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates.
Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG
Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717
[TBL] [Abstract] [Full Text] [Related]
10. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
[TBL] [Abstract] [Full Text] [Related]
11. Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism.
Abasolo I; Wang Z; Montuenga LM; Calvo A
Biochem Biophys Res Commun; 2004 Sep; 322(3):878-86. PubMed ID: 15336545
[TBL] [Abstract] [Full Text] [Related]
12. Investigation of copper-PTSM as a PET tracer for tumor blood flow.
Mathias CJ; Welch MJ; Perry DJ; McGuire AH; Zhu X; Connett JM; Green MA
Int J Rad Appl Instrum B; 1991; 18(7):807-11. PubMed ID: 1787092
[TBL] [Abstract] [Full Text] [Related]
